Table 1 The clinical characteristics of patients in AR group, ATN group and control group

Case number

35

10

5

Age (years)

34.6 ± 10.1

36.3 ± 9.2

37.6 ± 11.5

Male: Female

28:7

6:4

4:1

Post-operation days

12.7 ± 6.4

31.1 ± 44.5^*

12.0 ± 5.3

Post-biopsy days

NA

1.1 ± 3.9

1.4 ± 3.4

Urine output (l/24 hours)

2.36 ± 0.44

1.67 ± 0.96^*

1.40 ± 0.66^*

sCr (μmol/l)

88.8 ± 21.9

256.3 ± 173.5^*

322.8 ± 179.1^*

Hb (g/l)

104.2 ± 15.7

88.6 ± 15.1^*

81.8 ± 14.4^*

MAP (mmHg)

95.3 ± 10.9

109.9 ± 11.2^*

107.7 ± 15.6^*

Tacrolimus: CsA

30:5

6:4

5:0

Tacrolimus trough concentration (ng/ml)

7.5 ± 1.6

8.4 ± 2.4^#

4.8 ± 1.6^*

CsA trough concentration (ng/ml)

320.5 ± 64.8

238.6 ± 89.6

NA